PV
Aarti Drugs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cefixime | Anti-infective (Antibiotic) | Approved/Commercial |
| Azithromycin | Anti-infective (Antibiotic) | Approved/Commercial |
| Ofloxacin | Anti-infective (Antibiotic) | Approved/Commercial |
| Diclofenac Sodium | Anti-inflammatory, Analgesic | Approved/Commercial |
| Metformin HCl | Anti-diabetic | Approved/Commercial |
| Losartan Potassium | Cardiovascular (Hypertension) | Approved/Commercial |
| Pantoprazole Sodium | Gastrointestinal (Anti-ulcer) | Approved/Commercial |
| Steroids & Hormones Portfolio | Multiple (Dermatology, Hormone Therapy) | Approved/Commercial |
Leadership Team at Aarti Drugs
YS
Yogesh S. Kothari
Chairman & Managing Director
MM
Mukund M. Kothari
Whole-time Director
SS
Sushil S. Kothari
Whole-time Director
CS
Chandrakant S. Kothari
Whole-time Director
RG
Rajendra G. Kothari
Whole-time Director
SK
Sunil K. Jain
Chief Financial Officer
AY
Anagha Y. Kothari
Independent Director
PN
Pradip N. Kothari
Independent Director
SS
Shailesh S. Vaidya
Independent Director
PM
Pramod M. Kothari
Independent Director